These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24885292)

  • 1. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
    Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
    BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Beclin-1 in patients with hepatocellular carcinoma.
    Sun H; Yu J; Wen Z; Wang M; Chen W
    J BUON; 2019; 24(2):634-641. PubMed ID: 31128017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.
    Ding ZB; Shi YH; Zhou J; Qiu SJ; Xu Y; Dai Z; Shi GM; Wang XY; Ke AW; Wu B; Fan J
    Cancer Res; 2008 Nov; 68(22):9167-75. PubMed ID: 19010888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).
    Yang Y; Zhu J; Gou H; Cao D; Jiang M; Hou M
    Med Oncol; 2011 Sep; 28(3):796-803. PubMed ID: 20401641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
    Wu DH; Jia CC; Chen J; Lin ZX; Ruan DY; Li X; Lin Q; Min-Dong ; Ma XK; Wan XB; Cheng N; Chen ZH; Xing YF; Wu XY; Wen JY
    Tumour Biol; 2014 Dec; 35(12):12225-33. PubMed ID: 25256671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.
    Huang GW; Ding X; Chen SL; Zeng L
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1213-8. PubMed ID: 21647678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Beclin-1, an autophagy-related marker, in chronic hepatitis and hepatocellular carcinoma and its relation with apoptotic markers.
    Al-Shenawy HA
    APMIS; 2016 Mar; 124(3):229-37. PubMed ID: 26756998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis.
    Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y
    BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.
    Ma S; Yang J; Li J; Song J
    Tumour Biol; 2016 Jun; 37(6):7405-12. PubMed ID: 26676639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
    Ahn S; Hyeon J; Park CK
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).
    Bao YX; Cao Q; Yang Y; Mao R; Xiao L; Zhang H; Zhao HR; Wen H
    Diagn Pathol; 2013 Dec; 8():197. PubMed ID: 24313979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters.
    Baspinar S; Bircan S; Yavuz G; Kapucuoglu N
    Pathol Res Pract; 2013 Jul; 209(7):418-23. PubMed ID: 23722017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.
    Zhu JY; Sun QK; Wang W; Jia WD
    Int J Clin Exp Pathol; 2014; 7(6):2925-33. PubMed ID: 25031711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
    Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
    Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
    Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
    Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
    Masuda GO; Yashiro M; Kitayama K; Miki Y; Kasashima H; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Masaichi O; Hirakawa K
    Anticancer Res; 2016 Jan; 36(1):129-36. PubMed ID: 26722036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
    Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.